Novel Device for Improving Ostomy Skin Condition
The status, timeline and source of this project. A free account opens every field.
Source: EU Funding & Tenders Portal
Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health. There is enormous opportunity to address needs in the ostomy market, with 40% of all ileostomy and urostomy patients suffering from skin complications. The Ostoform Seal- the company’s f
- Status
- Closed
- Sector
- Hospital, Manufacturing (Industrial), Education
- Location
- Ireland
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Novel Device for Improving Ostomy Skin Condition
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health. There is enormous opportunity to address needs in the ostomy market, with 40% of all ileostomy and urostomy patients suffering from skin complications. The Ostoform Seal- the company’s first, award-winning product- uses a unique, patented combination of absorbent and non-absorbent materials to prevent acidic output from contacting the patient’s skin. Patient benefits of this product include healthier skin, better usability, increased patient confidence and improved patient quality of life. The devicecan also reduce costs for healthcare systems by reducing visits to ostomy nurses and by reducing the frequency with whichpatients change their ostomy bags. The addressable patient population for the Ostoform Seal is approximately 1,000,000 in the EU and US combined, resulting in an annual market of $725m. The device is a Class I medical device with a clear regulatory pathway and pre-existing reimbursement in the US. A 45% improvement in skin condition has already been demonstrated in a six-week study involving 12 patients. Following completion of the SME Instrument Phase I, Ostoform has secured €1.1m in private investment. This capital, along with SME Instrument Phase 2 funding will support further patient trials, which in turn will improve reimbursement pricing for the device. A full manufacturing line will also be established, with the company being fully market ready by December 2020. |
Location
Country | Ireland |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Manufacturing (Industrial), Education |
Article published date | 2026-02-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Ireland
- Glanbia Ingredients Ireland (GIL) Dairy Processing Facility, Belview
- Bristol Myers Squibb Biologics Manufacturing Facility, County Dublin
- SAFC Pharma API Manufacturing Expansion, Republic of Ireland
- Pfizer’s Biotechnology Campus, Clondalkin, Ireland
- Janssen Sciences’ Biomedicines Manufacturing Facility, Ringaskiddy, Ireland
- Centocor Biopharmaceutical
- Genzyme Manufacturing Expansion, Waterford
- Pfizer’s Synthesis Facility, Ringaskiddy, Ireland
